Biostatistics Services is IDDI’s DNA and Core Competence
Advanced Statistical Methodology and Operational Excellence for
Leaner and Faster Clinical Trials
Biostatistics is at the heart of every clinical study, driving study design, protocol development, clinical data collection, data analysis, and reporting.
IDDI delivers optimal study designs, best practice randomization methods, regular independent checks of the randomization balance, CRF review, and timely statistical analysis in order to produce clinical trial results that are scientifically accurate, validated, and reproducible.
Biostatistics is the backbone of the company. With scientific roots and in-depth clinical and regulatory experience, our team understands the scientific issues, anticipating and overcoming potential challenges specific to your clinical trial.
Complete Range of Advanced Biostatistics Services
From study inception to delivery of clinical study report, our skilled biostatisticians are involved at all steps of the clinical trial process to increase efficiency of our clients’ clinical drug development. Our expert biostatisticians offer flexible and innovative solutions for clinical research, and are not afraid to challenge the status quo.
- Strategic Consulting Services
- Study Design
- Choice of Endpoints
- Adaptive Design
- Sample size Calculation
- Trial Simulations
- Validation of Surrogate Endpoints
- Statistical input to publications
- Translational Research
- Biomarker-IVD Validation
- Randomization list and kit lists
- CRF Review
- Statistical Analyses
- Statistical Analysis Plan (SAP)
- Data Monitoring Committees (DMC)
- Interim Analyses
- Futility Analysis
- Dry runs
- CDISC Standards: Mapping SDTM into ADaM
- Validation of Randomization Algorithms
- Statistical Reports and Appendices
- TLF Creation
- Meta Analysis
- ISS, ISE
- Representation at the Regulatory Authorities (FDA/EMA)
UNRIVALED EXPERIENCE IN BIOSTATISTICS
Since IDDI’s creation in 1991, more than 350 pharmaceutical and biotechnology companies, as well as academic cooperative groups and CROs worldwide, have relied successfully on our expert biostatistics services, statistical consulting, operational excellence, unbiased expertise, independent data quality assessments capabilities and regulatory-compliant procedures to optimize the value of their clinical trials.
In-depth experience in a range of therapeutic areas, paired with profound understanding of ICH GCP, regulatory requirements and ADaM analysis datasets, ensures quality throughout all stages of drug development.
Our Biostatistics team includes 40+ statisticians with a master’s degree or above (including 10+ with doctoral-level training).
Some of our statisticians have also received medical degrees.
Our strong team of biostatisticians and statistical programmers produce high quality, reproducible, timely analysis and reporting of clinical trial results across all therapeutic areas. All of our statisticians and statistical programmers receive ongoing, intensive training inside and outside the company to deliver premium biostatistics and statistical programming services.
- SAS or R programming
- Standard SAS reporting macros
- Specialized software for sample-size calculation and group sequential designs (EaST®)
“IDDI performed an excellent job on the data management, IWRS and EDC functions for our large phase 2 study, and the statistical work was outstanding. The statistical group was extremely responsive and flexible, and despite the time difference between the U.S and Belgium the process was seamless and the response was extremely fast, even when the workload was very demanding. The output from the statistical group was meticulous and precise during a period of very ambitious timelines”.
Dr. Samir Patel, President and CEO, Ophthotech, Princeton, NJ, USA
IDDI is member of THE AMERICAN STATISTICAL ASSOCIATION